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1. Introduction     
Micro electrode array (MEA)-based platforms have been used to study neuronal networks 
for decades. The used cells have, for the most part, been rodent primary neurons. The 
gained knowledge has indeed increased the understanding of neuronal network 
development and maturation both in vitro and in vivo. If aiming to understand the 
development of human brain, however, the used cell type should preferably be of human 
origin due to difficult interpolation from the rodent cell data. In addition, the development 
of functional human neuronal networks would open up a new era for, e.g., toxicology 
testing, drug screening and disease modelling. 
The use of MEA with bioelectrically active cells was first reported by Thomas et al. 1972. 
Gross et al. (1977; 1979) extended the applicability of the MEA platform to long-term 
recordings of neuronal cells and Pine (1980) reported the first recordings from dissociated 
neurons. Interestingly, although the solutions related to the MEA fabrication and design 
were similar in the above mentioned papers, all three groups came to their conclusions 
independently demonstrating the drive and need to record neurons in vitro. MEAs have 
been successfully tested in several species and cell types using organotypic and primary 
dissociated cell cultures. Due to their ease of use, the long-term survival of the cultures and 
vast possibilities of manipulation of the culture, MEAs provide an attractive tool to explore 
basic neuroscience as well as for pharmacology and toxicology.  
Functional neuronal networks have been derived from mouse embryonic stem cells (Evans 
& Kaufman 1981; Martin 1981), but the invention of culturing human embryonic stem cells 
(Thomson et al., 1998) and human induced pluripotent stem cells (Takahashi et al., 2007) 
have enabled the researchers to build up human cell-derived neuronal cells and networks 
(Ban et al., 2006; Carpenter et al., 2001; Heikkilä et al., 2009; Karumbayaram et al., 2009; Nat 
et al., 2007). These studies have proved that human pluripotent stem cell-derived neuronal 
cells are indeed capable of forming functional neuronal networks which most likely 
resemble the networks in human brain. These human-derived neuronal networks have 
increased and will further increase the understanding of human brain development and 
functions. More importantly, with these networks it is possible to model the “normal” brain 
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by using human embryonic stem cell-derived neuronal cells and various diseases can be 
modelled when using patient specific induced pluripotent stem cell-derived neuronal cells. 
In addition, these cell types are suitable for drug screening and neurotoxicological studies. 
This chapter will shortly introduce the neuronal differentiation of both human embryonic 
stem cells and human induced pluripotent stem cells. Also, MEA platforms will be 
discussed concentrating especially on the use of MEAs with human pluripotent stem cell-
derived neuronal networks. Finally, some future aspects will be discussed. 
2. MEA technology 
The structure of the MEAs is simple. They consist of a glass slide that has wire electrodes 
photo-etched onto it. Each electrode is insulated from each other (e.g. by silicon nitrate) and 
only the tip of the electrode is coated with conductive material, such as titanium, platinum, 
or indium-tin oxide. Typically, the electrode size is 10 – 30 µm and they are aligned in a grid 
with 50 – 500 µm separation from the centres of the electrodes (Johnstone et al., 2010; Pine 
2006), MEAs measure the potential difference between a common ground electrode and the 
measurement electrodes. Because the measured voltage differences between the ground and 
the measurement electrodes are small and the locations of the electrodes are static, the 
reduction of noise and the amplification of the recorded signals are crucial. Often, the whole 
MEA chip is placed inside of the amplifier to ensure minimal distance between the 
electrodes and the amplifiers. 
To make hydrophobic MEA surface more appealing to neurons, the surface is often coated 
with different protein solutions like extracellular proteins (e.g. laminin, fibronectin, 
polylysines). Surfaces can be also pre-treated with Poly(ethyleneimine) (PEI) that enhances 
the coating procedure  (Heikkilä et al., 2009; Illes et al., 2007; Wagenaar et al., 2006).    
Cells grown on MEAs can be continuously perfused with fresh medium, but because this is 
a cumbersome and laborious task, the medium is usually replaced on a weekly basis. 
Different laboratories have different routines for medium replacement depending on the 
available staff and type and amount of the cells used in the experiments. Sensitive cells, such   
 
 
Fig. 1. A typical MEA setup. The Array is located inside an amplifier that is connected to an 
analog to digital converter on a computer. Bidirectional information transfer allows timing 
of the stimulations and more sophisticated study designs.  
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as hESC-derived neuronal cells, require fresh medium at least three times a week (Heikkilä 
et al., 2009). Typically, only one third or half of the medium is replaced in order to maintain 
more stable culturing conditions. Change of full medium would generate a massive change 
in the cellular microenvironment due to differences in the ionic and osmotic concentrations 
in the fresh and used growth media. Frequent change of the growth medium requires 
continuous handling of the MEAs and exposes the cultured neurons to an additional stress 
and contaminants in the laboratory. Thus, there is always a trade-off between the optimal 
medium composition and risk of contamination. After the introduction of the semi-
permeable transparent hydrophobic membrane (Potter & DeMarse 2001) that seals the MEA 
from the surroundings allowing only gas exchange it has been possible to record and 
maintain neuronal cultures on MEAs for months or even years without evaporation or 
contamination problems (Heikkilä et al., 2009; Illes et al., 2009; Potter & DeMarse 2001). 
These long and stable experiments are a prerequisite e.g. for chronic toxicology experiments.   
2.1 Functional MEA studies 
One of the first functional MEA studies was performed by Corner & Ramkers (1991) who 
evaluated the activity changes of maturing neurons grown on MEAs using tetrodotoxin and 
picrotoxin in long-term culture. After inclusion of the stimulation electrode into the MEA 
design (Gross et al., 1993), the applicability of MEAs to conduct functional studies improved 
significantly. Modern imaging methods, such as gated neurotransmitters, calcium imaging 
and voltage sensitive dyes (Mennerick et al., 2010) have further enhanced the usability of the 
MEA platform.  
Although neurons grown on a MEA chip form 2-dimensional networks that lack 
physiological input from the environment, they form functional spontaneously active 
networks that typically develop in 3 phases. First, activity is detected as single spiking that 
can reflect both axonal and dendritic signalling in the developing network. Second, as 
network maturates, it starts to express a train-like spiking activity that can further mature 
into burst -like activity that is considered as mature signalling activity of the network 
(Heikkilä et al., 2009; Wagenaar et al., 2006). The described types of signalling are 
represented in Figure 2. These functional networks can interact with the environment by 
selectively responding to the artificial cues presented by the stimulation apparatus. Jimbo 
and co-workers demonstrated that repetitive stimulation reinforces the synchronicity on 
MEA grown networks (Jimbo et al., 1998). However, firing of the neurons is pathway-
specific and stimulation may either promote or suppress the network firing activity 
depending on the stimulation location (Jimbo et al., 1999).  Stimulations can also be used to  
 
 
Fig. 2. Development of signalling in MEA. (A) First, after the neuronal cells have grown few 
days on MEA, first signals are detected. They are individual single spikes. (B) Then, about 
after 1-2 weeks of culturing spiking activity matures into training phase. There are several 
spikes organised together.  (C) Finally, bursting activity occurs. Burst is a complex signal 
package that happens in several channels at the same time.  
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tune network firing activity. Shahaf & Marom (2001) introduced a method of learning by 
stimulus removal on MEA grown dissociated cortical neuronal networks. It seems that MEA 
grown neurons can communicate in an activity-dependent manner that resembles the 
behaviour of intact neurons in vivo. On MEAs, this communication typically occurs in bursts 
of synchronous spikes, whose pathways (Jimbo et al., 1999), timing (Shahaf & Marom 2001), 
type (Wagenaar et al., 2006) and initiation (Eytan & Marom 2006) can be considered as 
variables for systemic activity changes.   
2.2 MEA analyses 
Most commonly, routines of MEA research follow the paths of decades of research in in vivo 
and in vitro electrophysiology. Due to the ease of use of MEAs and the benefits of 
dissociated culturing, the speed of the experiments is, however, much faster. Furthermore, 
due to elevated control over experimental conditions and variables in culture, the 
reproducibility of the experiments is more reliable and large sample sizes easily attainable.   
Raw data is usually high-pass filtered to extract spikes from the raw data. Additional 
sorting may be applied to obtain unit data. Although many laboratories have in-house 
MATLAB scripts to do the task, commercial softwares also exist. Traditional scatter plots, 
time histograms and time-frequency analyses are commonly used as analysis tools for MEA 
data. As in psychology and medicine, stimulus averaged methods are common for triggered 
data. On a network scale, separation of activity regimes (Tanskanen et al., 2005), analysis of 
bursts (Mazzoni et al., 2007) and pattern clustering (Madhavan et al., 2007) are challenging 
the traditional estimations of network cross-correlations. Synfire chains (Abeles 1982; 
Tetzlaff et al., 2002), avalanches (Beggs & Plenz 2003; 2004) and unitary events (Gruen et al., 
2002; Gruen 2009) are emerging as computational tools for more complex MEA network 
analysis. MEA data presentation can be found in Figure 3. 
3. Human pluripotent stem cells and their neural differentiation 
Short-term in vitro culturing of the inner cell mass of human blastocysts was first reported 
on 1994 (Bongso et al., 1994), but the successful isolation, culturing and characterization of 
human embryonic stem (hES) cells was reported 4 years later (Thomson et al., 1998). These 
cells are referred as human pluripotent stem cells due to their capability to form every cell 
type of the human body. After the discovery, hES cell research was intensively conducted 
for almost 10 years before remarkable progress took place with the invention of human 
induced pluripotent stem (hiPS) cells. These cells are formed from somatic cells by viral 
reprogramming (Takahashi et al., 2007; Yu et al., 2007) and they closely resemble hES cells 
by their characteristics. Thus, currently term human pluripotent stem cells includes both 
hES and hiPS cells (Figure 4). Most of the work cited here have been conducted using hES 
cells and their neural derivatives. 
Originally hES cells were cultured in their undifferentiated stage on mouse embryonic 
fibroblasts as feeder cells (Thomson et al., 1998) but shortly after also on human foreskin 
fibroblasts (Hovatta et al., 2003). Several feeder-free systems have also been studied with 
success on maintaining hES cells in undifferentiated form (Benzing et al., 2006; Gerrard et 
al., 2005; Hakala et al., 2009). There are clear indications, however, that hES cells cultured 
without feeder cells exhibit more abnormalities caused by suboptimal culture conditions 
and enzymatic passaging in long-term cultures (Imreh et al., 2006; Mitalipova et al., 2005).  
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Fig. 3. MEA data and its analysis. A) Typical recorded MEA signal streams on 60 electrodes. 
Each small window represents a signal from one MEA electrode. Note the noisy electrodes 
41 and 67 which appear all black. B) MEA activity plotted as a channel wise scatter plot. 
Each vertical line represents an electrode and each dot marks a spike recorded on that 
electrode. The easiest way to separate spikes is to draw a threshold based on standard 
deviation of the signal (e.g. 5*SD) and accept all crossings of the threshold as spikes. Note 
the stimulus responses and artefacts present on all the channels from 600 s to 1200 s. C) Peri-
stimulus time histogram of the selected channels in B. This histogram sums stimulus aligned 
responses and thus presents an average response to a given stimulus. Arrows below the 
figures show the timing of individual stimulus in a train of stimuli. Note the elevation of the 
spike rate in response to repetitive stimulus. D) Rate plot of the whole MEA recording. This 
3D plot clarifies the parameters of time, electrode channels and spikes/sec in a single figure.  
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Fig. 4. Stem cells. Stem cells can be divided in groups in accordance to their differentiation 
capacity. Embryos in zygote and morula stages are defined as totipotent. In blastocyst stage 
the inner cell mass is capable of producing the three germ layers and primordial germ cells, 
thus defined as pluripotent embryonic stem cells (ESCs). Adult cells can be re-programmed 
to produce embryonic stem cell-like pluripotent cells (iPS cells). Original images prepared 
by Cathrine Twomey from the National Academies Understanding stem cells: An Overview of 
the Science and Issues, http://www.nationalacademies.org/stemcells. 
Thus, the culture conditions of hES cells have been systematically improved towards 
containing only human or synthetic components. Similarly, hiPS cells need to be cultured on 
top of a feeder cell layer to avoid the spontaneous differentiation of these cells. This aspect 
has been widely studied due to ultimate aim to elude the use of feeder cells altogether. 
Undifferentiated human pluripotent stem cells can not be used for disease modelling or 
regenerative medicine as such due to their massive teratoma formation capacity (Adewumi et 
al., 2007; Skottman et al., 2007; Thomson et al., 1998). Indeed, neuronal differentiation of 
human pluripotent stem cells has been widely studied. The first articles on neural 
differentiation of hES cells were published 2001 (Carpenter et al., 2001; Reubinoff et al., 2001; 
Zhang et al., 2001) and of hiPS cells 2009 (Chambers et al., 2009; Karumbayaram et al., 2009). 
All of these protocols relied on embryoid body (EB) formation and/or further replating of the 
cells on appropriately coated surfaces in neural differentiation medium. Regardless of the 
differentiation methods used, these studies all showed that neural progenitors, specific 
neuronal cells, astrocytes and, to a lesser extent, oligodendrocytes could be produced. Since 
then, several methods and protocols for neural differentiation of hES and also hiPS cells have 
been published. Some groups utilize co-culture method with e.g. PA-6 stromal cells (Aberdam 
et al., 2008; Pomp et al., 2008) whereas other groups differentiate the cells with medium 
including minimum amounts of animal material (Lappalainen et al., 2010; Nat et al., 2007) or in 
totally defined animal-component free medium (Erceg et al., 2008; Yao et al., 2006). 
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Methodologically hES cells can be differentiated towards neural lineages using adherent 
and suspension culture systems or their various combinations with the help of specific 
factors facilitating differentiation. These factors include basic fibroblast growth factor 
(bFGF) (Benzing et al., 2006; Lappalainen et al., 2010), bone morphogenic protein signalling 
blocker noggin (Gerrard et al., 2005; Itsykson et al., 2005; Li et al., 2008) or retinoic acid 
(Baharvand et al., 2007; Erceg et al., 2008). Thus, the production of neural progenitors and 
specific neuronal phenotypes from hES cells appears to be possible with many methods, 
growth factors and inducing agents. The functionality of the produced neuronal cells has 
not, however, been taken into consideration on a large scale in relation to the differentiation 
protocol. HiPS cells have been neurally differentiated with the same methods as hES cells 
but the electrical functionality of hiPS cell-derived neuronal cells has so far been studied 
only with patch clamp technology (Karumbayaram et al., 2009). 
4. MEA and pluripotent stem cell-derived neuronal networks 
In neural applications MEA setup has traditionally been used with rodent primary cells. 
With pluripotent stem cell-derived neural cells the research has been conducted just over a 
decade but for now only a few groups have reported the usage of MEA with neuronal 
networks derived from pluripotent stem cells (Ban et al., 2006; Heikkilä et al., 2009; Illes et 
al., 2007). To date, little is known about the electrical properties of the pluripotent stem cell-
derived neuronal cells, their maturation, and network development and function.  
The first articles describing the measurement of murine ES cell-derived neuronal networks 
were published 5 years ago  (Ban et al., 2006; Illes et al., 2007). Both of these studies showed 
that the cells were capable of forming spontaneously active networks. Further, the activity 
developed from single spikes into more complex trains and bursts over time (Ban et al., 2006; 
Illes et al., 2007). The first study reporting successful measurement of human ES cell-derived 
neuronal networks with MEA was reported two years later (Heikkilä et al., 2009). This is a 
vital step in human research (Table 1) due to possible interspecies differences of developed 
neuronal networks. Especially with toxicological and drug studies, the specific pathways play 
important role in evaluating results and the translation between different species have to be 
take into account. For example, mouse embryonic stem cell-derived neuronal cells need 
JAK/STAT pathway activation whereas for the human ones activin/nodal and FGF signalling 
are important. These differences may cause large variation to results in drug responses. Thus, 
it might be meaningful to test toxicological effects directly on human cells (Hardingham et al., 
2010). Indeed, we recently performed a neurotoxicological evaluation of methyl mercury in 
human neuronal cell-based MEA platform (Ylä-Outinen et al., 2010). In this study we reported 
that at subcytotoxic levels methyl mercury caused changes in functionality of neuronal 
networks whereas no alterations were detected with standard molecule biological analyses 
(Ylä-Outinen et al., 2010). 
MEAs with ES cell-derived neuronal networks can also be used for studying the 
fundamental properties of these networks by pharmaceutical modulation. It has been shown 
that these networks, from human or mouse origin, contain functional glutamate and GABA 
receptors as they respond to AMPA/kainate, NMDA and GABAA receptor blockers 
(Heikkilä et al., 2009; Illes et al., 2007). These results are similar to results from rodent 
dissociated primary cultures (Kamioka et al., 1996; Corner & Ramakers 1991). Thus, human 
cell-based MEA platforms offer intriguing possibilities to conduct large scale in vitro drug 
screening and testing thereby reducing the need to use experimental animals. In addition, 
usage of human cells makes the translation into clinical setting more direct. 
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Research field Benefits of using MEA networks from human origin 
Basic research Cell-cell signalling  
Cellular and network connectivity  
Receptor expression and functionality 
Developmental studies Time course of development of cell types and networks  
Developmental disorders  
Intervention in development  
Toxicological studies Study of toxicological mechanisms  
On-site-sampling  
Continuous screening  
Acute and chronic responses  
Drug screening High throughput  
Standardized environment  
Animal-free testing   
Regenerative medicine Functionality of cell grafts 
Verification of uniform graft quality  
Graft-host tissue interactions  
Table 1. Research fields that benefit from the information gained with human cell-based 
MEA measurements. 
Dissociated neuronal networks have capacity and plasticity to learn in vitro. This has been 
shown by electrical stimulation of neuronal populations on MEA (e.g. Shahaf & Marom 
2001). Also, mES cell-derived neuronal networks have the ability to process information as 
shown by Ban and co-workers (Ban et al., 2006). They varied the intensity of the stimulus 
and showed that the neuronal networks responded to the intensity change. We have gained 
similar results with hES cell-derived neuronal cells (Heikkilä et al., 2009).  
The electrophysiological properties of hiPS cell-derived neuronal cells have not been 
extensively studied. So far, a few groups have described hiPS cell-derived neuronal cell 
functions with patch clamp on a single cell level (Karumbayaram et al., 2009; Swistowski et 
al., 2010). The ability of these cells to form spontaneously active networks has been 
somewhat questionable. Here, for the first time we show that neuronal cells derived from 
normal hiPS cell line, indeed, form functional neuronal networks. This functionality was 
evidenced on MEAs already two days after cell plating. The activity evolved from single 
spikes to complex burst patterns within four weeks similarly to hES cell-derived 
counterparts as shown in Figure 5. In future, neurological diseases with genetic background 
can be modelled with patient-specific hiPS cell lines as already published with e.g. inherited 
metabolic disorders in liver (Rashid et al., 2010) or long QT-syndrome in heart with patch 
clamp (Moretti et al., 2010). Because neuronal networks rely on electrical communication, 
especially the modelling of neurological diseases would crucially benefit from MEA 
platform. MEA-based disease models have already been introduced. For example, Otto et al. 
show that mES cell-derived neuronal networks respond by lowered signalling when 
cultured in cerebrospinal fluid of brain trauma patients (Otto et al., 2009). 
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Fig. 5. Comparison of electrical and molecular properties of hES and hiPS cell-derived 
neuronal networks. Array wide plots of spontaneous activity of hES and hiPS cell-derived 
neuronal networks on MEA. After one week single spiking and training activity is occurring 
in both hES and hiPS cell-derived cultures. After four weeks both cultures show developed 
bursting activity. The cells are verified as neuronal cells with immunostaining. 3D-histograms 
present the responses of the hES and hiPS cell-derived neuronal networks to pharmaceuticals. 
First, the baseline activity was measured. Thereafter, the addition of 30 µM CNQX and 20 
µM D-AP5 suppressed the activity. The activity of the networks reappeared when CNQX 
and D-AP5 were washed out. GABA-addition (100 µM) blocks the signalling whereas 30 µM 
bicuculline restored the signalling again. In 3D-histograms recording time [s] is represented 
by the y-axis and recorded channels in x-axis. The spike rate, spikes/second, is displayed on 
the z-axis. 
5. Future perspectives 
MEA-based platforms have been fairly satisfactorily established, yet several challenges still 
remain. For example, the large variation between individual MEA plates after cell seeding as 
well as the poor repeatability of connectivity in network development are areas that require 
improvement. One of the fruitful new approaches to reduce trial variability is a cell-cage 
(Erickson et al., 2008) where single cells on a network can be individually monitored. Future of 
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MEA technology will be 3-dimensional when moving towards stem cell technologies and cell 
therapies. It is essential to construct more in vivo-like environment where the whole culture 
can be screened in 3D. Similar approach is also important for toxicology and pharmacology to 
mimic tissues as accurately as possible. The current research has used mainly young, 
heterogeneous neuronal networks and in the future more efforts should be put into producing 
and measuring specific, well-characterized neuronal subtypes such as glutaminergic, 
GABAergic or dopaminergic neurons. This approach would bring MEA platforms closer to 
clinical relevance. For example, controlled co-cultures of various neuronal subtypes and glial 
cells would offer a tailored tool for clinical pharmacology and toxicology. 
Also more relevant, standardized and more robust data analysis protocols should be 
developed. In addition to existing analysis protocols, companies, such as NeuroProof GmbH 
(Rostock, Germany), have developed protocols where hundreds of different parameters are 
evaluated from the functional networks (Schröder, et al., 2010). In practice, it seems that 
analysis focusing on different parameters on overall spiking activity and burst amount, 
duration and mean frequency are quite good indicators of networks’ responses to different 
treatments (Hardingham, 2010), but these protocols are not standardised between laboratories.  
Clearly there is need for new kinds of analysis platforms as thousands of substances in EU 
area only should be screened for toxicological effects. Thus, MEA-based human cell platforms 
can offer new tools to take end point testing from animals (LD50, lethal dose for 50%) to cells 
(EC50, effective concentration in 50%) for testing more subtle and sensitive end points, such as 
alterations in neuronal activity patterns. Importantly, as there is a great need to reduce, replace 
and refine animal experiments, these functional level platforms will help to achieve this 
important goal. This goal requires that standardization and validation are seen as critical 
development points for the reproducibility and reliability of the MEA technology. 
6. Conclusions 
As MEA platforms have been shown to enable more accurate and refined analyses of for 
example developmental biology and neurotoxicity, the use of MEAs is expected to expand 
in the future. Some issues still, however, remain and efforts should be concentrated on 
improving e.g. the repeatability of the measurement platforms and setups. 
7. Acknowledgements 
Professor Timo Otonkoski, Professor Anu Wartiovaara, Riikka Hämäläinen and Ras 
Trokovic are acknowledged for collaboration with hiPS cells. The results presented here 
have been funded by Academy of Finland (projects 122959 and 123233), TEKES Stem in Clin, 
BioneXt Tampere, Competitive funding of Pirkanmaa hospital district and InterBrain 
University Alliance of Finland.  
8. References 
Abeles, M. (1982) Local Cortical Circuits: An Electrophysiological study. Springer, Berlin. 
Aberdam, E.; Barak, E.; Rouleau, M.; de LaForest, S.; Berrih-Aknin, S.; Suter, D.M.; Krause, 
K.H.; Amit, M.; Itskovitz-Eldor, J. & Aberdam, D. (2008). A pure population of 
ectodermal cells derived from human embryonic stem cells. Stem Cells, 26. 2.; 440-4.  
www.intechopen.com
Human Pluripotent Stem Cell-Derived Neuronal Networks:  
Their Electrical Functionality and Usability for Modelling and Toxicology   
 
469 
Adewumi, O.; Aflatoonian, B.; Ahrlund-Richter, L.; Amit, M.; Andrews, P.W.; Beighton, G.; 
Bello, P.A.; Benvenisty, N.; Berry, L.S.; Bevan, S.; Blum, B.; Brooking, J.; Chen, K.G.; 
Choo, A.B.; Churchill, G.A.; Corbel, M.; Damjanov, I.; Draper, J.S.; Dvorak, P.; 
Emanuelsson, K.; Fleck, R.A.; Ford, A.; Gertow, K.; Gertsenstein, M.; Gokhale, P.J.; 
Hamilton, R.S.; Hampl, A.; Healy, L.E.; Hovatta, O.; Hyllner, J.; Imreh, M.P.; 
Itskovitz-Eldor, J.; Jackson, J.; Johnson, J.L.; Jones, M.; Kee, K.; King, B.L.; Knowles, 
B.B.; Lako, M.; Lebrin, F.; Mallon, B.S.; Manning, D.; Mayshar, Y.; McKay, R.D.; 
Michalska, A.E.; Mikkola, M.; Mileikovsky, M.; Minger, S.L.; Moore, H.D.; 
Mummery, C.L.; Nagy, A.; Nakatsuji, N.; O'Brien, C.M.; Oh, S.K.; Olsson, C.; 
Otonkoski, T.; Park, K.Y.; Passier, R.; Patel, H.; Patel, M.; Pedersen, R.; Pera, M.F.; 
Piekarczyk, M.S.; Pera, R.A.; Reubinoff, B.E.; Robins, A.J.; Rossant, J.; Rugg-Gunn, 
P.; Schulz, T.C.; Semb, H.; Sherrer, E.S.; Siemen, H.; Stacey, G.N.; Stojkovic, M.; 
Suemori, H.; Szatkiewicz, J.; Turetsky, T.; Tuuri, T.; van den Brink, S.; Vintersten, 
K.; Vuoristo, S.; Ward, D.; Weaver, T.A.; Young, L.A. & Zhang, W. (2007). 
Characterization of human embryonic stem cell lines by the International Stem Cell 
Initiative. Nat Biotechnol, 25. 7.; 803-16. 
Baharvand, H.; Mehrjardi, N.Z.; Hatami, M.; Kiani, S.; Rao, M. & Haghighi, M.M. (2007). 
Neural differentiation from human embryonic stem cells in a defined adherent 
culture condition. Int J Dev Biol, 51. 5.; 371-8. 
Ban, J.; Bonifazi, P.; Pinato, G.; Broccard, F.; Studer, L.; Torre, V. & Ruaro, M.E. (2006). ES-
derived neurons form functional networks in vitro. Stem Cells, 25. 3.; 738-49. 
Beggs, J. M. & D. Plenz (2003). Neuronal avalanches in neocortical circuits. J Neurosci, 23. 35.; 
11167-77. 
Beggs, J. M. & D. Plenz (2004). Neuronal avalanches are diverse and precise activity patterns 
that are stable for many hours in cortical slice cultures. J Neurosci, 24. 22.; 5216-29. 
Benzing, C.; Segschneider, M.; Leinhaas, A.; Itskovitz-Eldor, J. & Brustle, O. (2006). Neural 
conversion of human embryonic stem cell colonies in the presence of fibroblast 
growth factor-2. Neuroreport, 17. 16.; 1675-81.  
Bongso, A.; Fong, C.Y.; Ng, S.C. & Ratnam, S. (1994). Isolation and culture of inner cell mass 
cells from human blastocysts. Hum Reprod, 9. 11.; 2110-7.  
Carpenter, M.K.; Inokuma, M.S.; Denham, J.; Mujtaba, T.; Chiu, C.P. & Rao, M.S. (2001). 
Enrichment of neurons and neural precursors from human embryonic stem cells. 
Exp Neurol, 172. 2.; 383-97.  
Chambers, S.M.; Fasano, C.A.; Papapetrou, E.P.; Tomishima, M.; Sadelain, M. & Studer, L. 
(2009). Highly efficient neural conversion of human ES and iPS cells by dual 
inhibition of SMAD signaling. Nat Biotechnol, 27. 3.; 275-80.  
Corner, M.A.  &  Ramakers,  G.J.  (1991)  Spontaneous  bio- electric activity as both 
dependent and independent variable in  cortical  maturation.  Chronic  tetrodotoxin  
versus  picrotoxin   effects   on   spike-train  patterns  in   developing  rat neocortex  
neurons  during  long-term  culture.  Ann.  NY Acad. Sci, 627.; 349–353. 
Erceg, S.; Lainez, S.; Ronaghi, M.; Stojkovic, P.; Perez-Arago, M.A.; Moreno-Manzano, V.; 
Moreno-Palanques, R.; Planells-Cases, R. & Stojkovic, M. (2008). Differentiation of 
human embryonic stem cells to regional specific neural precursors in chemically 
defined medium conditions. PLoS ONE, 3. 5. e2122.  
Erickson, J.C.; Tooker, A.; Tai, Y.-C. & Pine, J. (2008). Caged neuron MEA: A system for 
long-term investigation of cultured neural network connectivity. J Neurosci Meth, 
175., 1-16. 
Evans, M.J. & Kaufman, M.H. (1981). Establishment in culture of pluripotential cells from 
mouse embryos. Nature, 292. 5819.; 154-6.  
www.intechopen.com
 Methodological Advances in the Culture, Manipulation and  
Utilization of Embryonic Stem Cells for Basic and Practical Applications 
 
470 
Eytan, D. & Marom, S. (2006). Dynamics and effective topology underlying synchronization 
in networks of cortical neurons. J Neurosci, 26.; 8465–76. 
Gerrard, L.; Rodgers, L. & Cui, W. (2005). Differentiation of human embryonic stem cells to 
neural lineages in adherent culture by blocking bone morphogenetic protein 
signaling. Stem Cells, 23. 9.; 1234-41.  
Gross, G.W.; Rhoades, B.K.; Reust, D.L. & Schwalm FU.  (1993) Stimulation of monolayer 
networks in culture through thin film indium-tin oxide recording electrodes. J 
Neurosci Methods, 50.; 131–43. 
Gross, G.W. (1979). Simultaneous single unit recording in vitro with a photoetched laser 
deinsulated gold multi-microelectrode surface. IEEE Trans. Biomed. Eng, 26.; 273–
279. 
Gross, G.W.; Reiske, E.; Kreutzberg, G.W.; & Mayer, A. (1977). A new fixed-array mul- 
timicroelectrode system designed for long-term recording of extracellular single 
unit activity in vitro. Neurosci. Lett, 6.; 101–105. 
Hakala, H.; Rajala, K.; Ojala, M.; Panula, S.; Areva, S.; Kellomäki, M.; Suuronen, R. & H, S. 
(2009). Comparison of biomaterials and extracellular matrices as a culture platform 
for multiple, indeoendently derived human embryonic stem cell lines. Tissue Eng 
Part A, 15.; 1-12.  
Hardingham, G.E.; Patani, R.; Baxter, P.; Wyllie, D.J. & Chandran, S. (2010). Human 
embryonic stem cell-derived neurons as a tool for studying neuroprotection and 
neurodegeneration. Mol Neurobiol, 42. 1.; 97-102.  
Heikkilä, T.J.; Ylä-Outinen, L.; Tanskanen, J.M.; Lappalainen, R.S.; Skottman, H.; Suuronen, 
R.; Mikkonen, J.E.; Hyttinen, J.A. & Narkilahti, S. (2009). Human embryonic stem 
cell-derived neuronal cells form spontaneously active neuronal networks in vitro. 
Exp Neurol, 218. 1.; 109-16.  
Hovatta, O.; Mikkola, M.; Gertow, K.; Stromberg, A.M.; Inzunza, J.; Hreinsson, J.; Rozell, B.; 
Blennow, E.; Andang, M. & Ahrlund-Richter, L. (2003). A culture system using 
human foreskin fibroblasts as feeder cells allows production of human embryonic 
stem cells. Hum Reprod, 18. 7.; 1404-9.  
Illes, S.; Fleischer, W.; Siebler, M.; Hartung, H.P. & Dihne, M. (2007). Development and 
pharmacological modulation of embryonic stem cell-derived neuronal network 
activity. Exp Neurol, 207. 1.; 171-6.  
Illes, S.; Theiss, S.; Hartung, H.P.; Siebler, M. & Dihne, M. (2009). Niche-dependent 
development of functional neuronal networks from embryonic stem cell-derived 
neural populations. BMC Neurosci, 10. 93. 
Imreh, M.P.; Gertow, K.; Cedervall, J.; Unger, C.; Holmberg, K.; Szoke, K.; Csoregh, L.; Fried, 
G.; Dilber, S.; Blennow, E. & Ahrlund-Richter, L. (2006). In vitro culture conditions 
favoring selection of chromosomal abnormalities in human ES cells. J Cell Biochem, 
99. 2.; 508-16.  
Itsykson, P.; Ilouz, N.; Turetsky, T.; Goldstein, R.S.; Pera, M.F.; Fishbein, I.; Segal, M. & 
Reubinoff, B.E. (2005). Derivation of neural precursors from human embryonic 
stem cells in the presence of noggin. Mol Cell Neurosci, 30. 1.; 24-36.  
Jimbo, Y.; Robinson, H.P. & Kawana, A. (1998). Strengthening of synchronized activity by 
tetanic stimulation in cortical cultures: application of planar electrode arrays. IEEE 
Trans Biomed Eng, 45. 11.; 1297-304.  
Jimbo, Y.; Tateno, T. & Robinson, H.P. (1999). Simultaneous induction of pathway-specific 
potentiation and depression in networks of cortical neurons. Biophys J, 76. 2.; 670-8.  
www.intechopen.com
Human Pluripotent Stem Cell-Derived Neuronal Networks:  
Their Electrical Functionality and Usability for Modelling and Toxicology   
 
471 
Johnstone, A.F.; Gross, G.W.; Weiss, D.G.; Schroeder, O.H.; Gramowski, A. & Shafer, T.J. 
(2010). Microelectrode arrays: a physiologically based neurotoxicity testing 
platform for the 21st century. Neurotoxicology, 31. 4.; 331-50. 
Kamioka, H; Maeda, E; Jimbo, Y; Robinson, H.P. & Kawana A. (1996) Spontaneous periodic 
synchronized bursting during formation of mature patterns of connections in 
cortical cultures. Neurosci Lett. 206(2-3):109–112  
Karumbayaram, S.; Novitch, B.G.; Patterson, M.; Umbach, J.A.; Richter, L.; Lindgren, A.; 
Conway, A.E.; Clark, A.T.; Goldman, S.A.; Plath, K.; Wiedau-Pazos, M.; Kornblum, 
H.I. & Lowry, W.E. (2009). Directed differentiation of human-induced pluripotent 
stem cells generates active motor neurons. Stem Cells, 27. 4.; 806-11.  
Lappalainen, R.S.; Salomäki, M.; Ylä-Outinen, L.; Heikkilä, J.T.; Hyttinen, J.A.K.; Suuronen, 
R.; Skottman, H. & Narkilahti, S. (2010). Similarly derived and cultured hESC lines 
show variation in their developmental potential towards neuronal cells in long-
term culture. Regen Med, 5(5):749-762  
Li, X.J.; Hu, B.Y.; Jones, S.A.; Zhang, Y.S.; Lavaute, T.; Du, Z.W. & Zhang, S.C. (2008). 
Directed differentiation of ventral spinal progenitors and motor neurons from 
human embryonic stem cells by small molecules. Stem Cells, 26. 4.; 886-93.  
Madhavan, R.; Chao, Z.C. & Potter, S.M. (2007). Plasticity of recurring spatiotemporal 
activity patterns in cortical networks. Phys. Biol, 4.; 181–193. 
Martin, G.R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in 
medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A, 78. 
12.; 7634-8.  
Mazzoni, A.; Broccard, F.D.; Garcia-Perez, E.; Bonifazi, P.; Ruaro, M.E. & Torre, V. (2007). 
On the Dynamics of the Spontaneous Activity in Neuronal Networks. PLoS ONE, 2. 
5.; e439. 
Mennerick, S.; Chisari, M.; Shu, H.-J.; Taylor, A.; Vasek, M.; Eisenman, L.N. & Zorumski, 
C.F. (2010). Diverse Voltage-Sensitive Dyes Modulate GABAAReceptor Function. J 
Neurosci, 30.8.; 2871-2879. 
Mitalipova, M.M.; Rao, R.R.; Hoyer, D.M.; Johnson, J.A.; Meisner, L.F.; Jones, K.L.; Dalton, S. 
& Stice, S.L. (2005). Preserving the genetic integrity of human embryonic stem cells. 
Nat Biotechnol, 23. 1.; 19-20.  
Moretti, A.; Bellin, M.; Welling, A.; Jung, C.B.; Lam, J.T.; Bott-Flugel, L.; Dorn, T.; Goedel, A.; 
Hohnke, C.; Hofmann, F.; Seyfarth, M.; Sinnecker, D.; Schomig, A. & Laugwitz, K.L. 
(2010). Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT 
Syndrome. N Engl J Med.  
Nat, R.; Nilbratt, M.; Narkilahti, S.; Winblad, B.; Hovatta, O. & Nordberg, A. (2007). 
Neurogenic neuroepithelial and radial glial cells generated from six human 
embryonic stem cell lines in serum-free suspension and adherent cultures. Glia, 55. 
4.; 385-99, 0894-1491. 
Otto, F.; Illes, S.; Opatz, J.; Laryea, M.; Theiss, S.; Hartung, H.P.; Schnitzler, A.; Siebler, M. & 
Dihne, M. (2009). Cerebrospinal fluid of brain trauma patients inhibits in vitro 
neuronal network function via NMDA receptors. Ann Neurol, 66. 4.; 546-55.  
Pine, J. (2006). A history of MEA development. Advances in network electrophysiology. 
Pine, J. (1980). Recording action potentials from cultured neurons with extracellular 
microcircuit electrodes. J Neurosci Methods, 2. 1.; 19-31. 
Pomp, O.; Brokhman, I.; Ziegler, L.; Almog, M.; Korngreen, A.; Tavian, M. & Goldstein, R.S. 
(2008). PA6-induced human embryonic stem cell-derived neurospheres: a new 
source of human peripheral sensory neurons and neural crest cells. Brain Res, 1230.; 
50-60.  
www.intechopen.com
 Methodological Advances in the Culture, Manipulation and  
Utilization of Embryonic Stem Cells for Basic and Practical Applications 
 
472 
Potter, S.M. & DeMarse, T.B. (2001). A new approach to neural cell culture for long-term 
studies. J Neurosci Methods, 110. 1-2.; 17-24.  
Rashid, S.T.; Corbineau, S.; Hannan, N.; Marciniak, S.J.; Miranda, E.; Alexander, G.; Huang-
Doran, I.; Griffin, J.; Ahrlund-Richter, L.; Skepper, J.; Semple, R.; Weber, A.; Lomas, 
D.A. & Vallier, L. (2010). Modeling inherited metabolic disorders of the liver using 
human induced pluripotent stem cells. J Clin Invest, 120. 9.; 3127-36.  
Reubinoff, B.E.; Itsykson, P.; Turetsky, T.; Pera, M.F.; Reinhartz, E.; Itzik, A. & Ben-Hur, T. 
(2001). Neural progenitors from human embryonic stem cells. Nat Biotechnol, 19. 12.; 
1134-40.  
Shahaf, G. & Marom, S. (2001). Learning  in  networks  of cortical neurons. J Neurosci, 21.; 
8782–8788. 
Schröder, O.H-U.; Weiss D.G.; Jügelt, K. & Gramowski, A. (2010). Profiling of acute 
neurotoxic effects of insect repellents with MEA-neurochip technology. Conf. Proc. 
7th International Meeting on Subtrate-Integrated Micro Electrode Arrays, Reutlingen, 
Germany, June-July 2010. 
Skottman, H.; Narkilahti, S. & Hovatta, O. (2007). Challenges and approaches to the culture 
of pluripotent human embryonic stem cells. Regen Med, 2. 3.; 265-73.  
Swistowski, A.; Peng, J.; Liu, Q.; Mali, P.; Rao, M.S.; Cheng, L. & Zeng, X. (2010). Efficient 
Generation of Functional Dopaminergic Neurons from Human Induced pluripotent 
Stem Cells under Defined Conditions. Stem Cells.  
Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K. & Yamanaka, S. 
(2007). Induction of pluripotent stem cells from adult human fibroblasts by defined 
factors. Cell, 131. 5.; 861-72.  
Tanskanen, J.M.A.; Mikkonen, J.E. & Penttonen, M. (2005). Independent component analysis 
of neural populations from multielectrode field potential measurements. J Neurosci 
Methods, 145. 1-2.; 213-232. 
Tetzlaff, T.; Geisel, T. & Diesmann M. (2002). The ground state of cortical feed-forward 
networks. Neurocomputing, 44-46.; 673-678. 
Thomas, C.A.; Springer, P.A.; Loeb, G.E.; Berwald-Netter, Y. & Okun, L.M. (1972). 
A miniature microelectrode array to monitor the bioelectric activity of cultured 
cells. Exp Cell Res, 74.; 61–66. 
Thomson, J.A.; Itskovitz-Eldor, J.; Shapiro, S.S.; Waknitz, M.A.; Swiergiel, J.J.; Marshall, V.S. 
& Jones, J.M. (1998). Embryonic stem cell lines derived from human blastocysts. 
Science, 282. 5391.; 1145-7.  
Wagenaar, D.A.; Pine, J. & Potter, S.M. (2006). An extremely rich repertoire of bursting 
patterns during the development of cortical cultures. BMC Neurosci, 7. 11.  
Yao, S.; Chen, S.; Clark, J.; Hao, E.; Beattie, G.M.; Hayek, A. & Ding, S. (2006). Long-term 
self-renewal and directed differentiation of human embryonic stem cells in 
chemically defined conditions. Proc Natl Acad Sci U S A, 103. 18.; 6907-12.  
Ylä-Outinen, L.; Heikkilä, J.; Skottman, H.; Suuronen, R.; Äänismaa, R. & Narkilahti, S. 
(2010). Human cell-based micro electrode array platform for studying 
neurotoxicity. Front Neuroeng, 3:111  
Yu, J.; Vodyanik, M.A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J.L.; Tian, S.; Nie, J.; 
Jonsdottir, G.A.; Ruotti, V.; Stewart, R.; Slukvin, II & Thomson, J.A. (2007). Induced 
pluripotent stem cell lines derived from human somatic cells. Science, 318. 5858.; 
1917-20.  
Zhang, S.C.; Wernig, M.; Duncan, I.D.; Brustle, O. & Thomson, J.A. (2001). In vitro 
differentiation of transplantable neural precursors from human embryonic stem 
cells. Nat Biotechnol, 19. 12.; 1129-33.  
www.intechopen.com
Methodological Advances in the Culture, Manipulation and
Utilization of Embryonic Stem Cells for Basic and Practical
Applications
Edited by Prof. Craig Atwood
ISBN 978-953-307-197-8
Hard cover, 506 pages
Publisher InTech
Published online 26, January, 2011
Published in print edition January, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Pluripotent stem cells have the potential to revolutionise medicine, providing treatment options for a wide
range of diseases and conditions that currently lack therapies or cures. This book describes methodological
advances in the culture and manipulation of embryonic stem cells that will serve to bring this promise to
practice.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Riikka Äänismaa, Laura Ylä-Outinen, Jarno E. Mikkonen and Susanna Narkilahti (2011). Human Pluripotent
Stem Cell-Derived Neuronal Networks:Their Electrical Functionality and Usability for Modelling and Toxicology,
Methodological Advances in the Culture, Manipulation and Utilization of Embryonic Stem Cells for Basic and
Practical Applications, Prof. Craig Atwood (Ed.), ISBN: 978-953-307-197-8, InTech, Available from:
http://www.intechopen.com/books/methodological-advances-in-the-culture-manipulation-and-utilization-of-
embryonic-stem-cells-for-basic-and-practical-applications/human-pluripotent-stem-cell-derived-neuronal-
networks-their-electrical-functionality-and-usability-f
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
